References
- Nef HM, Möllmann H, Akashi YJ, Hamm CW. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol. 2010;7(4):187–193. doi:10.1038/nrcardio.2010.16
- Prokudina ES, Kurbatov BK, Maslov LN. Клиническая картина стрессорной кардиомиопатии (синдром такотсубо) и проблема дифференциальной диагностики с острым инфарктом миокарда [Clinical manifestation of stressful cardiomyopathy (Takotsubo Syndrome) and the problem of differential diagnosis with acute myocardial infarction]. Kardiologiia. 2020;60(11):777. Russian. doi:10.18087/cardio.2020.11.n777
- Fang X, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680. doi:10.1073/pnas.1821022116
- Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi:10.1016/j.cell.2012.03.042
- Guo J, Xu B, Han Q, et al. Ferroptosis: a Novel Anti-tumor Action for Cisplatin. Cancer Res Treat. 2018;50(2):445–460. doi:10.4143/crt.2016.572
- Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. doi:10.1186/s13045-019-0720-y
- Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379. doi:10.1038/cdd.2015.158
- Angeli JPF, Shah R, Pratt DA, Conrad M. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38(5):489–498. doi:10.1016/j.tips.2017.02.005
- Wu X, Li Y, Zhang S, Zhou X. Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics. 2021;11(7):3052–3059. doi:10.7150/thno.54113
- Godsman N, Kohlhaas M, Nickel A, et al. Metabolic alterations in a rat model of takotsubo syndrome. Cardiovasc Res. 2022;118(8):1932–1946. doi:10.1093/cvr/cvab081
- Feng H, Stockwell BR. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203. doi:10.1371/journal.pbio.2006203
- Nef HM, Möllmann H, Troidl C, et al. Expression profiling of cardiac genes in Tako-Tsubo cardiomyopathy: insight into a new cardiac entity. J Mol Cell Cardiol. 2008;44(2):395–404. doi:10.1016/j.yjmcc.2007.10.015
- Re DP D, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765–1817. doi:10.1152/physrev.00022.2018
- Chen Y, Li X, Wang S, Miao R, Zhong J. Targeting iron metabolism and ferroptosis as novel therapeutic approaches in cardiovascular diseases. Nutrients. 2023;15(3):591. doi:10.3390/nu15030591
- Li G, Lei J, Xu D, et al. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms. Sci Rep. 2023;13(1):5770. doi:10.1038/s41598-023-33009-1
- Charoentong P, Finotello F, Angelova M, et al. Pan-cancer Immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–262. doi:10.1016/j.celrep.2016.12.019
- Dai B, Sun F, Cai X, et al. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of childhood asthma using the gene expression omnibus database. Front Genet. 2021;12:634162. doi:10.3389/fgene.2021.634162
- Gili S, Cammann VL, Schlossbauer SA, et al. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry. Eur Heart J. 2019;40(26):2142–2151. doi:10.1093/eurheartj/ehz170
- Di Vece D, Citro R, Cammann VL, et al. Outcomes associated with cardiogenic shock in Takotsubo syndrome. Circulation. 2019;139(3):413–415. doi:10.1161/circulationaha.118.036164
- Y-Hassan S. Clinical features and outcome of pheochromocytoma-induced Takotsubo syndrome: analysis of 80 published cases. Am J Cardiol. 2016;117(11):1836–1844. doi:10.1016/j.amjcard.2016.03.019
- Ranieri M, Finsterer J, Bedini G, Parati EA, Bersano A. Takotsubo syndrome: clinical features, pathogenesis, treatment, and relationship with cerebrovascular diseases. Curr Neurol Neurosci Rep. 2018;18(5):20. doi:10.1007/s11910-018-0833-7
- Batta A, Gupta AK, Singal G, et al. Autoimmune polyendocrine syndrome II presenting paradoxically as Takotsubo cardiomyopathy: a case report and reappraisal of pathophysiology. Egypt Heart J. 2022;74(1):82. doi:10.1186/s43044-022-00321-6
- Wilson HM, Cheyne L, Brown PAJ, et al. Characterization of the myocardial inflammatory response in acute stress-induced (Takotsubo) cardiomyopathy. JACC Basic to Transl Sci. 2018;3(6):766–778. doi:10.1016/j.jacbts.2018.08.006
- Bai YT, Chang R, Wang H, et al. ENPP2 protects cardiomyocytes from erastin-induced ferroptosis. Biochem Biophys Res Commun. 2018;499(1):44–51. doi:10.1016/j.bbrc.2018.03.113
- Beharier O, Tyurin VA, Goff JP, et al. PLA2G6 guards placental trophoblasts against ferroptotic injury. Proc Natl Acad Sci U S A. 2020;117(44):27319–27328. doi:10.1073/pnas.2009201117
- Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285–296. doi:10.1016/s1535-6108(03)00050-3
- Balboa MA, Balsinde J. Oxidative stress and arachidonic acid mobilization. Biochim Biophys Acta. 2006;1761(4):385–391. doi:10.1016/j.bbalip.2006.03.014
- Wang L, Zhang Y, Yang J, et al. The knockdown of ETV4 inhibits the papillary thyroid cancer development by promoting ferroptosis upon SLC7A11 downregulation. DNA Cell Biol. 2021;40(9):1211–1221. doi:10.1089/dna.2021.0216
- Xiao Z, Kong B, Fang J, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced cardiac dysfunction. Bioengineered. 2021;12(2):9367–9376. doi:10.1080/21655979.2021.2001913
- Díaz-García E, Nanwani-Nanwani K, García-Tovar S, et al. NLRP3 inflammasome overactivation in patients with aneurysmal subarachnoid hemorrhage. Transl Stroke Res. 2023;14(3):334–346. doi:10.1007/s12975-022-01064-x
- Sun K, Li YY, Jin J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct Target Ther. 2021;6(1):79. doi:10.1038/s41392-020-00455-6
- Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569(7755):270–274. doi:10.1038/s41586-019-1170-y
- Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med. 2015;66(1):97–110. doi:10.1146/annurev-med-051013-052304